High-Dose BCNU Followed by Autologous Hematopoietic Stem Cell Transplantation in Supratentorial High-Grade Malignant Gliomas: A Retrospective Analysis of 114 Patients

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1703889
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Brazilian Experience Using High-Dose Sequential Therapy (HDS) Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Malignant Lymphomas

Revista Brasileira de Hematologia e Hemoterapia
2009English

Dose-Intense BCNU/Melphalan Regimen Followed by Autologous Hematopoietic Cell Transplantation (AHCT) Results in Prolonged PFS in Myeloma Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

Biochemical Markers of Cardiotoxicity of High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation in Patients With Malignant Lymphoproliferative Disorders

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2016English

High-Dose BCNU/Melphalan Conditioning Regimen Before Autologous Stem Cell Transplantation in Newly Diagnosed Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2017English

High Dose Chemotherapy (HDT) With Busulfan, Melphalan and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) in Pediatric Patients (Pts) With High Risk Solid Tumors

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Is High-Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplantation in Breast Cancer Patients a Done Deal?

Women's Health
Medicine
2010English

High Dose BCNU Chemotherapy With Autologous Bone Marrow Transplantation and Full Dose Radiotherapy for Grade IV Astrocytoma

British Journal of Cancer
Cancer ResearchOncology
1988English

Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy